Projekt

Fatigue in Multiple Sclerosis now and then: a cross-sectional study

Abgeschlossen · 2009 bis 2009

Art
Klinische Forschung
Reichweite
Monozentrisch am KSSG
Bereiche
Status
Abgeschlossen
Start
2009
Ende
2009
Finanzierungsart
Eigenfinanzierung
Studiendesign
open lable cross-sectional phase IV
Schlagwörter (Tags)
multiple sclerosis, natalizumab, disease modifying treatment, fatigue
Kurzbeschreibung/Zielsetzung

Fatigue is one of the major concerns of MS patients. Disease modifying drugs (DMD) may have an impact on fatigue prevalence and severity. The current study aims to analyze fatigue severity with new disease modifying agents compared to previous investigations with older DMD.